HIMSS Summer 2004

Genomics made a well-received appearance at the HIMSS summer conference.:

“Genomic Medicine: Data Management for the Future of Healthcare”
Speaker: Philip Chen, MD, PhD
Co-founder of the Cognoscenti Health Institute

No proceedings to point to yet, just a program here or a better one here.

If the proceedings for the recent meeting are posted, I’ll let you know. While you’re waiting, if you haven’t taken a look at the proceedings from the recent annual meeting, George Poste gave a talk of interest (check out the powerpoint):

Session #: 74
Topic: Leadership
Genetics and Computing :The Evolution of Molecular Medicine and e-Health
George Poste, DVM, PhD

BioHistory Part II

In early April I wrote about The Chicago Historical Society’s efforts to examine the implications of biohistorical analysis.  If you recall, the Chicago Historical Society (CHS) faced a dilemma regarding whether to allow genetic testing of materials presumably containing blood from Abe Lincoln.  Various parties were interested in peforming analysese on this material in order to determine whether Lincoln had Marfan Syndrome.  So, the CHS commissioned a review of professional codes in order establish guidelines for biohistorical analysis.  This group published an article in Science describing their efforts (a web-enhanced version is availble for free too):

Lori Andrews et al. Constructing Ethical Guidelines for Biohistory. Science April 9 2004.

Today AMNews published a nice article following up on this story:

Andis Robeznieks. Uncloaking history: The ethics of digging up the past. AMNews. June 28, 2004.

 

Impact of Clinical Genomics Assessed

Gwen Acton “Clinical Genomics: The Impact of Genomic Technology on Clinical Trials and Medical Practice” Cambridge Healthtech Advisors. (136 pages @ ~$20/page so not for the merely curious).

Genetic screening for the benefits of exercise

An example of a genetic test intended to help medical consumers make lifestyle choices appears to have emerged.  According to this press release, BodyMedia has negotiated an exclusive license to genetic technologies based on research “investigating what a person’s genes say about how much their health can benefit from a moderate exercise program.”  This research has been led by Dr. James M. Hagberg of University of Maryland (nice biography here, scroll down; publications here).  Dr. Hagberg’s “team has identified genetic markers that predict particularly significant exercise benefits for patients with a variety of conditions, including high cholesterol, hypertension, diabetes, osteoporosis, and obesity.”  According to an article in the Pittsburgh Business Times, BodyMedia “will integrate the university’s genetics-based guidance with its health-monitoring products.”   

Back from Break

Will start blogging again this week after a little break.